Deferasirox use after hematopoietic stem cell transplantation in pediatric patients with beta-thalassemia major: preliminary results.
dc.contributor.author | Unal, Sule | |
dc.contributor.author | Kuskonmaz, Baris | |
dc.contributor.author | Hazırolan, Tuncay | |
dc.contributor.author | Eldem, Gonca | |
dc.contributor.author | Aytac, Selin | |
dc.contributor.author | Cetin, Mualla | |
dc.contributor.author | Uckan, Duygu | |
dc.contributor.author | Gumruk, Fatma | |
dc.date.accessioned | 2020-10-21T12:39:48Z | |
dc.date.available | 2020-10-21T12:39:48Z | |
dc.date.issued | 2010 | |
dc.identifier.uri | http://hdl.handle.net/11655/23008 | |
dc.language.iso | en | tr_TR |
dc.rights | info:eu-repo/semantics/openAccess | tr_TR |
dc.subject | Deferasirox use | tr_TR |
dc.subject | Hematopoietic stem cell transplantation | |
dc.title | Deferasirox use after hematopoietic stem cell transplantation in pediatric patients with beta-thalassemia major: preliminary results. | tr_TR |
dc.type | info:eu-repo/semantics/article | tr_TR |
dc.contributor.department | Acil Tıp | tr_TR |
dc.description.index | WoS | tr_TR |
dc.funding | Yok | tr_TR |